Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $103.61, moving +1.02% from the previous trading session.

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

by Zacks Equity Research

Abbott Laboratories' (ABT) Established Pharmaceuticals Division (EPD) and Diabetes arm are boosting business in recent months.

Earnings Preview: Abbott (ABT) Q1 Earnings Expected to Decline

by Zacks Equity Research

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TG Therapeutics (TGTX) Surges 22.8%: Is This an Indication of Further Gains?

by Zacks Equity Research

TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NOBL

The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Advanced Micro Devices, Intuit and Cintas

by Zacks Equity Research

T-Mobile US, Abbott Laboratories, Advanced Micro Devices, Intuit and Cintas are included in this Analyst Blog.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $102.80, marking a +1.19% move from the previous day.

Sheraz Mian headshot

Top Stock Reports for T-Mobile US, Abbott Laboratories & AMD

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stock, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Advanced Micro Devices, Inc. (AMD).

Abbott's (ABT) Epic Max Tissue Valve Receives FDA Approval

by Zacks Equity Research

Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $98.46 in the latest trading session, marking a +0.42% move from the prior day.

Abbott's (ABT) CardioMEMS Favors Heart Failure Management

by Zacks Equity Research

Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.

Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Here's Why You Should Retain Abbott (ABT) Stock for Now

by Zacks Equity Research

Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Abbott (ABT) Stock Moves 0.89%: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $97.87, moving +0.89% from the previous trading session.

Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes

by Zacks Equity Research

Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $98.55 in the latest trading session, marking a +0.37% move from the prior day.

Sheraz Mian headshot

Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and ConocoPhillips (COP).

Abbott (ABT) to Pair CGM Sensors & AID System on FDA Clearance

by Zacks Equity Research

Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.

Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DEF

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $99.40, marking a -0.58% move from the previous day.

Abbott (ABT) Gets FDA Nod for Alinity I Laboratory Test

by Zacks Equity Research

Abbott's (ABT) Alinity i TBI lab test provides a new reliable result in 18 minutes to support clinicians in quickly assessing concussion and triaging patients.

Abbott (ABT) Reveals Favorable Data on Tricuspid Regurgitation

by Zacks Equity Research

Abbott Laboratories (ABT) demonstrates the superiority of the TriClip device in treating patients with severe, symptomatic tricuspid regurgitation.

Zacks Investment Ideas feature highlights: Procter and Gamble, Johnson & Johnson and Abbott Labs

by Zacks Equity Research

Procter and Gamble, Johnson & Johnson and Abbott Labs have been highlighted in this Investment Ideas article.

Ethan Feller headshot

3 Value Stocks on Sale Now

by Ethan Feller

Growth stocks have clearly led the market thus far in 2023, but will that continue?